Maggot debridement therapy in chronic wound care
- PMID: 17914145
Maggot debridement therapy in chronic wound care
Abstract
Objective: To review the current evidence on the mechanism of actions and clinical applications of maggot debridement therapy.
Data sources: Literature search of PubMed and Medline was performed up to January 2007.
Study selection: Original and major review articles related to maggot debridement therapy were reviewed. Key words used in the literature search were 'maggot debridement therapy', 'wound healing', and 'chronic wound management'.
Data extraction: All relevant English and Chinese articles.
Data synthesis: The mechanism of such maggot therapy was shown to be due to the debridement, disinfection, and wound healing enhancement actions of maggot excretions/secretions. The efficacy of maggot debridement therapy in chronic wound management has been demonstrated in chronic venous ulcers, pressure ulcers, and diabetic ulcers. There is also a new delivery system for the excretions/secretions, which has been shown to be as effective as using live maggots.
Conclusions: Maggot debridement therapy has been shown to be a safe and effective means of chronic wound management. However, there are a number of limitations when considering its local applicability. Future development of the delivery system may help to overcome some of these limitations and improve its acceptability.
Similar articles
-
[Maggot therapy in wound management].Tidsskr Nor Laegeforen. 2009 Sep 24;129(18):1864-7. doi: 10.4045/tidsskr.08.0656. Tidsskr Nor Laegeforen. 2009. PMID: 19844278 Review. Norwegian.
-
The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.J Wound Care. 2012 Feb;21(2):78, 80, 82-85. doi: 10.12968/jowc.2012.21.2.78. J Wound Care. 2012. PMID: 22584527
-
Clinical research on the bio-debridement effect of maggot therapy for treatment of chronically infected lesions.Orthop Surg. 2010 Aug;2(3):201-6. doi: 10.1111/j.1757-7861.2010.00087.x. Orthop Surg. 2010. PMID: 22009949 Free PMC article.
-
Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.BMC Biotechnol. 2016 Mar 22;16:30. doi: 10.1186/s12896-016-0263-z. BMC Biotechnol. 2016. PMID: 27006073 Free PMC article.
-
Does maggot therapy promote wound healing? The clinical and cellular evidence.J Eur Acad Dermatol Venereol. 2016 May;30(5):776-82. doi: 10.1111/jdv.13534. Epub 2015 Dec 21. J Eur Acad Dermatol Venereol. 2016. PMID: 26691053 Review.
Cited by
-
[Cutaneous wound healing. Therapeutic interventions].Hautarzt. 2010 Jul;61(7):611-26; quiz 627. doi: 10.1007/s00105-010-1978-8. Hautarzt. 2010. PMID: 20556349 German.
-
Maggot debridement therapy in the treatment of complex diabetic wounds.Hawaii Med J. 2011 Jun;70(6):121-4. Hawaii Med J. 2011. PMID: 22162609 Free PMC article.
-
Debridement of Diabetic Foot Ulcers.Adv Wound Care (New Rochelle). 2022 Dec;11(12):666-686. doi: 10.1089/wound.2021.0016. Epub 2021 Dec 21. Adv Wound Care (New Rochelle). 2022. PMID: 34376065 Free PMC article. Review.
-
Excretions/secretions from bacteria-pretreated maggot are more effective against Pseudomonas aeruginosa biofilms.PLoS One. 2012;7(11):e49815. doi: 10.1371/journal.pone.0049815. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23226221 Free PMC article.
-
Antiviral and virucidal activities of Lucilia cuprina maggots' excretion/secretion (Diptera: Calliphoridae): first work.Heliyon. 2019 Nov 20;5(11):e02791. doi: 10.1016/j.heliyon.2019.e02791. eCollection 2019 Nov. Heliyon. 2019. PMID: 31844722 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources